Evidence map›Paper›PMID 34919440›Full record

ArticleThe British journal of radiology2022

The role of

Weifang Wang, Xiaochen Ni, Tianci Tang, Jie Wang, Yi Li, Xinmao Song

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The British journal of radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Weifang WangDepartment of Radiation Oncology, Ear, Nose & Throat Hospital of Fudan University, Shanghai, China.
Xiaochen NiDepartment of Radiation Oncology, Ear, Nose & Throat Hospital of Fudan University, Shanghai, China.
Tianci TangDepartment of Radiation Oncology, Ear, Nose & Throat Hospital of Fudan University, Shanghai, China.
Jie WangDepartment of Radiation Oncology, Ear, Nose & Throat Hospital of Fudan University, Shanghai, China.
Yi LiDepartment of Oncology, 920th Hospital of Joint Logistics Support Force, Kunming, China.
Xinmao SongDepartment of Radiation Oncology, Ear, Nose & Throat Hospital of Fudan University, Shanghai, China.ORCID 0000-0002-4265-1851
Obstetrics and Gynecology Hospital of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe purpose of this study is to evaluate the value of fluorine-18-fludeoxyglucose positron emission tomography (

methods70 patients with OAML who received radiotherapy were recruited in our study. All the patients had the

resultsThe PET/CT scan indicated that 80% (56/70) of the patients showed orbital FDG avidity. The median level of maximum standardized uptake value (SUVmax) of the lesions was 4.65 ± 3.00 (range:1.2-13.5). 92.0% (46/50) of the mass-forming lesions showed

conclusionADVANCES IN KNOWLEDGE: The value of

Indexed as

Positron Emission Tomography Computed TomographyAdultAgedAged, 80 and overAntibodies, ViralConjunctivaEpstein-Barr Virus InfectionsEye NeoplasmsFemaleFluorodeoxyglucose F18Herpesvirus 4, HumanHumansKi-67 AntigenLacrimal ApparatusLymphoma, B-Cell, Marginal ZoneMaleAntibodies, ViralFluorodeoxyglucose F18Ki-67 AntigenRadiopharmaceuticals

Identifiers

PMID34919440
PMCPMC8822575
OpenAlexW4200321938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.